|
DovonexDrug - Dovonex The trade name of the product as shown on the labeling.
Dosage -
SOLUTION; TOPICAL
Active Ingredient(s) -
Calcipotriene
Strength -
0.005%
Applicant -
BRISTOL MYERS SQUIBB
New Drug Application (NDA) Number -
020611
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Mar 3, 1997
Reference Listed Drug (RLD) -
Yes
Type -
RX
Applicant Full Name -
Bristol Myers Squibb Co Pharmaceutical Research Institute
Dovonex
Dovonex 0.005% Ointment; Topical
Dovonex 0.005% Solution; Topical Cafergot 100mg;1mg Tablet; Oral Cafergot 100mg;1mg Tablet; Oral Ergotamine Tartrate And Caffeine 100mg;1mg Tablet; Oral Ergotamine Tartrate And Caffeine 100mg;1mg Tablet; Oral Wigraine 100mg;1mg Tablet; Oral Calderol 0.02mg Capsule; Oral Calderol 0.05mg Capsule; Oral Dovonex 0.005% Cream; Topical NewDrugInformation |